Lee Ainslie's ELV Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 3,465 shares of Elevance Health, Inc. (ELV) worth $1.35 M, representing 0.01% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 34 quarters.
Based on 13F filings, Lee Ainslie has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2018, adding 1.01 M shares. Largest reduction occurred in Q2 2019, reducing 724,153 shares.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +3,465 | New Buy | 3,465 | $388.82 |
| Q1 2024 | -2,057 | Sold Out | 0 | $0.00 |
| Q4 2023 | +2,057 | New Buy | 2,057 | $471.56 |
| Q3 2023 | -1,889 | Sold Out | 0 | $0.00 |
| Q2 2023 | +1,889 | New Buy | 1,889 | $444.29 |
| Q1 2023 | -508 | Sold Out | 0 | $0.00 |
| Q4 2022 | -36 | Reduce 6.62% | 508 | $512.97 |
| Q3 2022 | +544 | New Buy | 544 | $454.04 |
| Q2 2022 | -3,729 | Sold Out | 0 | $0.00 |
| Q1 2022 | +3,217 | Add 628.32% | 3,729 | $491.28 |
| Q4 2021 | -89 | Reduce 14.81% | 512 | $462.89 |
| Q3 2021 | -5,468 | Reduce 90.10% | 601 | $372.71 |
| Q2 2021 | +5,878 | Add 3077.49% | 6,069 | $381.78 |
| Q1 2021 | +71 | Add 59.17% | 191 | $361.26 |
| Q4 2020 | -10,934 | Reduce 98.91% | 120 | $325.00 |
| Q3 2020 | +2,691 | Add 32.18% | 11,054 | $268.59 |
| Q2 2020 | -7,030 | Reduce 45.67% | 8,363 | $262.94 |
| Q1 2020 | +15,393 | New Buy | 15,393 | $227.05 |
| Q2 2019 | -724,153 | Sold Out | 0 | $0.00 |
| Q1 2019 | -169,596 | Reduce 18.98% | 724,153 | $286.98 |
| Q4 2018 | -150,413 | Reduce 14.41% | 893,749 | $262.63 |
| Q3 2018 | +1.01 M | Add 3059.34% | 1.04 M | $274.05 |
| Q2 2018 | -6,380 | Reduce 16.18% | 33,050 | $238.03 |
| Q1 2018 | +10,230 | Add 35.03% | 39,430 | $219.71 |
| Q4 2017 | +10,560 | Add 56.65% | 29,200 | $225.00 |
| Q3 2017 | +5,810 | Add 45.28% | 18,640 | $189.86 |
| Q2 2017 | +4,540 | Add 54.76% | 12,830 | $188.15 |
| Q1 2017 | -240 | Reduce 2.81% | 8,290 | $165.38 |
| Q4 2016 | -950 | Reduce 10.02% | 8,530 | $143.73 |
| Q3 2016 | +180 | Add 1.94% | 9,480 | $125.32 |
| Q2 2016 | +870 | Add 10.32% | 9,300 | $131.29 |
| Q1 2016 | +2,690 | Add 46.86% | 8,430 | $139.03 |
| Q4 2015 | +890 | Add 18.35% | 5,740 | $139.37 |
| Q3 2015 | +4,850 | New Buy | 4,850 | $140.00 |
Lee Ainslie's Elevance Health Investment FAQs
Lee Ainslie first purchased Elevance Health, Inc. (ELV) in Q3 2015, acquiring 4,850 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Elevance Health, Inc. (ELV) for 34 quarters since Q3 2015.
Lee Ainslie's largest addition to Elevance Health, Inc. (ELV) was in Q3 2018, adding 1,044,162 shares worth $286.15 M.
According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 3,465 shares of Elevance Health, Inc. (ELV), valued at approximately $1.35 M.
As of the Q3 2026 filing, Elevance Health, Inc. (ELV) represents approximately 0.01% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Elevance Health, Inc. (ELV) was 1,044,162 shares, as reported at the end of Q3 2018.